Study guide

6.5 Pressure Injury Prevention, Staging, and Treatment Scenarios

Wound Care Certified WCC

Track your progress as you read

Finished sections get a check mark.

1 Orientation: NAWCO WCC Exam, Eligibility, and Scoring

1.1 Credential Purpose, Sponsor, and Scope 1.2 Qualifying License and Eligibility Frame 1.3 Education and Experience Pathways 1.4 Exam Format, Delivery, and Timing 1.5 Scoring, Standard Setting, and Confidentiality 1.6 Fees, Scheduling, Retesting, and Recertification

2 Wound Assessment: Etiology, Status, and Skin Integrity

2.1 Assessment Domain and Exam Approach 2.2 Etiology Patterns and Location Clues 2.3 Wound Status: Measurement, Tissue, and Exudate 2.4 Depth, Tissue Loss, and Pressure Injury Language 2.5 Skin Structure, Function, and Barrier 2.6 Skin Integrity Across the Lifespan

3 Patient Assessment: Labs, Nutrition, Pain, and Risk Tools

3.1 Labs and Diagnostic Data in Wound Assessment 3.2 Nutrition, Hydration, and Healing Risk 3.3 Comorbidities, Medications, and Current Condition 3.4 Psychosocial History, Adherence Barriers, and Access 3.5 Pain Assessment Tools and Treatment Tolerance 3.6 Risk Tools, Cognition, Function, and ADLs

4 Treatment Foundations, Dressings, and Wound Bed Preparation

4.1 Cleansing, Wound Hygiene, and Assessment Before Treatment 4.2 Moisture Balance and Core Dressing Functions 4.3 Dressing Categories, Formulary, and Resource Fit 4.4 Periwound Protection, Exudate, and Securement 4.5 Wound Bed Preparation and Debridement Concepts 4.6 Infection Signs, Prevention, and Escalation

5 Advanced Therapies, Diagnostics, Support Surfaces, and Referrals

5.1 Negative Pressure Wound Therapy Readiness and Monitoring 5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts 5.3 Diagnostics, Cultures, Labs, and Referral Triggers 5.4 Support Surfaces, Pressure Redistribution, and Microclimate 5.5 Offloading, Compression, and Lymphedema Decision-Making 5.6 Hyperbaric Oxygen and Specialty Referral Coordination

6 Infection, Vascular, Diabetic, and Pressure Injury Scenarios

6.1 Local, Spreading, and Systemic Infection Signals 6.2 Biofilm, Colonization, Culture, and Antimicrobial Traps 6.3 Diabetic Foot Ulcer Scenarios: Neuropathy, Perfusion, and Offloading 6.4 Venous, Arterial, and Mixed Vascular Wound Scenarios 6.5 Pressure Injury Prevention, Staging, and Treatment Scenarios 6.6 Integrated Contraindication and Priority Scenarios

7 Reevaluation, Healing Progression, and Treatment Adjustment

7.1 Re-Evaluation Domain and Decision Cycle 7.2 Treatment Choice and Plan Effectiveness 7.3 Weekly Measurement and Trend Monitoring 7.4 Tolerance, Pain, and Treatment Reactions 7.5 Adherence Barriers and Plan Adjustment 7.6 Healing Phases and Progression Decisions

8 Education, Health Literacy, and Interprofessional Teaching

8.1 Education Domain Scope and Priorities 8.2 Patient and Family Treatment-Plan Teaching 8.3 Health Literacy, Plain Language, and Teach-Back 8.4 Language, Cognition, Sensory Needs, and Cultural Adaptation 8.5 Discharge Teaching and Home Adherence 8.6 Interprofessional Team Teaching and Prevention Reinforcement

9 Administration, Protocols, Data Quality, and Care Coordination

9.1 Administration Domain Map for WCC Candidates 9.2 Evidence-Based Protocols and Facility Processes 9.3 Formularies, Product Access, and Treatment-Plan Workflow 9.4 Educational Media and Team Communication Tools 9.5 Data Quality, Prevalence, Incidence, and Outcome Monitoring 9.6 Payers, Case Management, and Transition Coordination

10 Legal Documentation, Ethics, Scope, and Patient Autonomy

10.1 Legal Domain Map for WCC Candidates 10.2 Objective Wound-Characteristic Documentation 10.3 Treatment-Plan Documentation and Continuity 10.4 Scope of Practice, Regulatory Issues, and Consultation 10.5 Ethics, Culture, Palliative Care, and Patient Autonomy 10.6 Confidentiality, Record Integrity, and Exam Conduct

11 Risk, Prevention, At-Risk Populations, and Product Selection

11.1 Risk Framework for Impaired Skin Integrity 11.2 Pressure Prevention, Repositioning, and Support Surfaces 11.3 Moisture, Incontinence, and Periwound Protection 11.4 Offloading, Foot Risk, and At-Risk Populations 11.5 Product Indications, Contraindications, and Selection 11.6 Population-Specific Prevention Across Settings

12 Integrated WCC Case Scenarios and Final Review

12.1 Blueprint-Weighted Final Review Strategy 12.2 Integrated Pressure Injury Case Review 12.3 Integrated Diabetic Foot and Vascular Case Review 12.4 Integrated Venous Leg Ulcer and Compression Case Review 12.5 Legal, Education, and Administration Integrated Cases 12.6 Exam Day, Scoring, Retake, and Recertification Review

6.5 Pressure Injury Prevention, Staging, and Treatment Scenarios

Key Takeaways Explain This Topic AI

Pressure injury scenarios combine risk assessment, skin inspection, support surfaces, repositioning, moisture control, nutrition, and documentation.

Staging follows the 2016 NPIAP system and depends on visible tissue depth, not on wound size, drainage amount, or pain.

Deep tissue pressure injury, unstageable pressure injury, and mucosal injury are common classification traps.

The exam trap is focusing on the wound dressing while leaving pressure, shear, moisture, or device pressure uncorrected.

Last updated: June 2026

Pressure injury scenarios start with force

Pressure injury content spans several WCC domains: Assessment (skin integrity, wound status, risk tools, function, cognition, nutrition, pain, comorbidities), Treatment (support surfaces and wound treatments), and Risk and Prevention (impaired skin integrity and at-risk populations). The exam expects an integrated plan , not just a staging label.

A pressure injury is localized damage to skin and underlying soft tissue, usually over a bony prominence or under a medical device, from intense or prolonged pressure, often combined with shear (2016 NPIAP definition). Prevention begins by identifying immobility, sensory loss, moisture, poor nutrition, perfusion problems, devices, friction, sedation, and cognitive impairment. The Braden Scale quantifies risk across six subscales (sensory perception, moisture, activity, mobility, nutrition, friction/shear); lower totals mean higher risk, with 18 or below generally flagged as at risk and 9 or below at very high risk.

The 2016 NPIAP staging system

Staging changed in 2016: "injury" replaced "ulcer," Arabic numerals replaced Roman numerals, and the categories were clarified. Stage 1 is intact skin with localized non-blanchable erythema. Stage 2 is partial-thickness loss with exposed dermis, often an intact or ruptured serum-filled blister (no slough, no granulation). Stage 3 exposes adipose and may show slough, undermining, or tunneling. Stage 4 exposes or has palpable fascia, muscle, tendon, ligament, cartilage, or bone.

  • Classification Key exam cue Common trap
  • Stage 1 Intact skin, non-blanchable erythema Calling it "not a wound" because skin is intact

Stage 2 Partial-thickness loss; intact or ruptured serum blister Mislabeling moisture-associated skin damage as pressure

  • Stage 3 Full-thickness loss, adipose visible Calling it Stage 2 because bone is not exposed
  • Stage 4 Visible/palpable fascia, muscle, tendon, or bone Staging by size instead of by depth
  • Unstageable Full-thickness loss obscured by slough or eschar Guessing a stage before the base is visible

Deep tissue pressure injury Persistent non-blanchable deep red, maroon, or purple intact skin, or blood-filled blister Waiting for skin to open before acting

Medical-device-related and mucosal pressure injuries are separate: mucosal injuries (mouth, nares, urethra) are not assigned a numeric stage because mucosal tissue histology differs from skin.

Worked scenario, treatment, and traps

Applied scenario: a bedbound patient has a dark purple, intact, painful heel. The best answer is not to massage it or wait until it opens. Offload the heel (float heels off the bed with a pillow under the calf or a heel-suspension device), assess perfusion, protect the skin, notify per policy, document the discoloration as a deep tissue pressure injury if criteria fit, review the support surface and turning plan, and monitor for evolution, since deep tissue injuries can deteriorate rapidly.

Staging is never based on wound size, drainage, infection, or pain; a small Stage 4 can be deeper than a large Stage 2. Treatment must always address pressure and shear: scheduled repositioning (commonly every 2 hours in bed and hourly when seated, individualized), an appropriate support surface, heel offloading, transfer technique, keeping the head of bed at or below 30 degrees when tolerated to limit shear, moisture/incontinence management, a nutrition referral (protein and calorie support, hydration), and pain control. A sacral foam dressing may protect skin but does not fix a patient sliding down in bed.

Device-related pressure is a recurring trap: oxygen tubing, masks, cervical collars, casts, splints, compression wraps, tubing, and footwear all injure tissue. Inspect under and around every device and pad or reposition per policy. Final traps: do not massage reddened skin (it can worsen deep injury) and do not use donut/ring cushions (they concentrate pressure). Never "reverse stage" a healing wound; a healing Stage 4 is described as a healing Stage 4 , not a Stage 2.

Support-surface selection and the blanch test

Support surfaces are matched to risk and mobility. Reactive surfaces (static foam, gel overlays) suit patients who can reposition independently and remain at moderate risk. Active/alternating-pressure mattresses cyclically shift load and suit high-risk, immobile patients or those with existing injuries who cannot offload a surface. The key exam principle is that a specialty surface supplements turning -- it never replaces it.

A practical bedside skill is the blanch test : press a reddened area; if it blanches (whitens then refills), it is likely Stage-1-pending or reactive hyperemia, whereas non-blanchable erythema confirms Stage 1 tissue damage. This is the line the exam draws between transient pressure response and a true injury.

Moisture, nutrition, and distinguishing MASD

A frequent classification trap is confusing moisture-associated skin damage (MASD) , such as incontinence-associated dermatitis, with a pressure injury. MASD is typically diffuse, in skin folds or the perineum, with irregular borders and no relation to a bony prominence, and it is managed with a structured skin-care regimen: gentle cleansing, a moisturizer, and a moisture barrier or breathable absorbent product. Pressure injuries, by contrast, localize over bony prominences and follow the pressure-and-shear pattern.

Nutrition is a named prevention pillar: identify malnutrition risk, ensure adequate protein, calories, and fluids, and trigger a dietitian referral, because no support surface or dressing closes a wound in a protein-depleted patient. Tie every plan to the patient's goals -- a comfort-focused patient may decline aggressive turning, and honoring that documented choice is appropriate care, not neglect.